Attilio Olivieri

Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report

Daniel Wolff, Anita Lawitschka, Sandra A. Mitchell, 2022 .

Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.

Pietro Leoni, Francesco Alesiani, P. Galieni, 2006, Blood.

A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel

Monia Marchetti, Marco Risso, Luca Pierelli, 2014, Transfusion.